ArticleCell communication and signaling : CCS2023

A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways.

Celia X-J Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.